JON B. ROUSSEAU - 12 Jun 2025 Form 4 Insider Report for BrightSpring Health Services, Inc. (BTSG)

Signature
/s/ Jennifer Phipps, as Attorney-in-Fact
Issuer symbol
BTSG
Transactions as of
12 Jun 2025
Transactions value $
-$8,179,699
Form type
4
Filing time
13 Jun 2025, 16:03:24 UTC
Previous filing
29 Apr 2025
Next filing
29 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROUSSEAU JON B Title: Chairman, President and Chief Executive Officer, Director C/O BRIGHTSPRING HEALTH SERVICES, INC., 805 N. WHITTINGTON PARKWAY, LOUISVILLE /s/ Jennifer Phipps, as Attorney-in-Fact 13 Jun 2025 0001579775

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTSG Common Stock Options Exercise $3.39M +532K +44.91% $6.37 1.72M 12 Jun 2025 Direct F2
transaction BTSG Common Stock Sale -$11.6M -532K -30.99% $21.75 1.18M 12 Jun 2025 Direct F1, F2
holding BTSG Common Stock 370K 12 Jun 2025 By Rousseau Family Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTSG Stock Options (Right to Buy) Options Exercise $0 -532K -40.08% $0.00 795K 12 Jun 2025 Common Stock 532K $6.37 Direct F3
holding BTSG Stock Options (Right to Buy) 535K 12 Jun 2025 Common Stock 535K $6.37 By The Margaret Rousseau Children Trust F3, F4
holding BTSG Stock Options (Right to Buy) 378K 12 Jun 2025 Common Stock 378K $6.37 By Rousseau Family Trust F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 12, 2025, at a price of $21.75, before deducting underwriting discounts and commissions.
F2 Includes 564,599 shares of the Issuer's common stock underlying restricted stock units ("RSUs") which will vest in seven equal quarterly installments commencing on July 25, 2025 and 316,639 shares of the Issuer's common stock underlying RSUs which vest in eleven equal quarterly installments commencing on July 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement.
F3 These options are fully vested.
F4 The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.

Remarks:

Title: Chairman, President and Chief Executive Officer